Publicaciones (69) Publicaciones de EDUARDO MALMIERCA CORRAL

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Pellagra linked to maize consumption in Gambo, Ethiopia: A call for awareness

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Structural chronic insomnia in AIDS patient

    Acta Neurologica Belgica

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Modifying SARS-CoV-2 vaccine schedule in Spain: When numbers matters

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 3, pp. 150-151

  3. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid

    Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2

  3. Epidemiological characteristics of the COVID-19 outbreak in a secondary hospital in Spain

    American Journal of Infection Control, Vol. 49, Núm. 2, pp. 143-150

  4. Reply to: Integral management of COVID-19 in Madrid: Turning things around during the second wave

    LANCET REGIONAL HEALTH-EUROPE

  5. Reply to: Integral management of COVID-19 in Madrid: Turning things around during the second wave

    The Lancet Regional Health - Europe

2020

  1. Case report: Autochthonous Cutaneous Loxoscelism with Oedematous Predominance (CLEP) in Madrid, Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 6, pp. 296-297

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  4. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

  5. Latent and active tuberculosis infections in migrants and travellers: A retrospective analysis from the Spanish +REDIVI collaborative network

    Travel Medicine and Infectious Disease, Vol. 36

  6. Neurological complications in critical patients with COVID-19

    Neurologia, Vol. 35, Núm. 9, pp. 621-627

2019

  1. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network

    Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57

2018

  1. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real-world practice: Madrid coinfection registry findings

    Hepatology, Vol. 68, Núm. 1, pp. 32-47

  2. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38